Belite Bio CEO Yu-Hsin Lin Reports Another Stock Sale Under Trading Plan
A Form 4 filing with the SEC records a sale of 11,080 shares of Belite Bio common stock at $191.147 per share, executed under a trading plan.
Every insider sales report published for San Diego County, California, newest first.
A Form 4 filing with the SEC records a sale of 11,080 shares of Belite Bio common stock at $191.147 per share, executed under a trading plan.